Abstract
Background
S. aureus is one of the main pathogens involved in ruminant mastitis worldwide. The severity of staphylococcal infection is highly variable, ranging from subclinical to gangrenous mastitis. This work represents an in-depth characterization of S. aureus mastitis isolates to identify bacterial factors involved in severity of mastitis infection.
Methodology/Principal Findings
We employed genomic, transcriptomic and proteomic approaches to comprehensively compare two clonally related S. aureus strains that reproducibly induce severe (strain O11) and milder (strain O46) mastitis in ewes. Variation in the content of mobile genetic elements, iron acquisition and metabolism, transcriptional regulation and exoprotein production was observed. In particular, O11 produced relatively high levels of exoproteins, including toxins and proteases known to be important in virulence. A characteristic we observed in other S. aureus strains isolated from clinical mastitis cases.
Conclusions/Significance
Our data are consistent with a dose-dependant role of some staphylococcal factors in the hypervirulence of strains isolated from severe mastitis. Mobile genetic elements, transcriptional regulators, exoproteins and iron acquisition pathways constitute good targets for further research to define the underlying mechanisms of mastitis severity.
Introduction
Mastitis is an inflammation of the mammary gland with local and or general symptoms that occasionally result in a systemic infection. This disease has a profound impact on animal welfare and milk quality [1] leading to great economical losses in milk production [2]. Staphylococcus aureus is a major cause of mastitis in ruminants worldwide which is often difficult to cure and is prone to resurgence. Beside mastitis, S. aureus is involved in a wide range of infections. In several infection types (e.g. pneumonia, osteomyelitis, skin infections), extremely severe cases associated with hypervirulent strains have been reported [3]–[6]. The existence of hypervirulent strains emphasizes the need to define the strain characteristics involved in the increased severity so as to better monitor their dissemination and find relevant therapeutic targets to reduce severity. It has been reported that severity can be linked to the production of a single virulence factor that enhances the virulence of producing strains. For example, Panton-Valentine leukocidin, a bi-component pore-forming toxin, is particularly prevalent in severe infections [4] and has been proposed as a hypervirulent determinant [7], due to its involvement in leukocyte destruction and tissue necrosis [8], [9]. Furthermore, staphylococcal superantigens or alpha-toxin function in a dose-dependant manner, resulting in more severe infections caused by highly-expressing strains [10]–[13]. Severity of mastitis caused by Escherichia coli was shown to be mainly determined by host factors and not by the strains features [14]. In contrast, in S. aureus mastitis, inter-strain variations exist in terms of virulence potential [15]. Alpha-toxin and LukM-F' have been reported to be highly produced during gangrenous S. aureus mastitis [13], [16]–[19]. However, global studies which examine the expression of all proteins have not been carried out, and to date no gene has been identified as being a severity marker [20]–[22]. A better understanding of the pathogenicity of S. aureus is critical to develop more efficient and satisfactory therapy to overcome mastitis.
S. aureus strains O11 and 046 were isolated from gangrenous mastitis and subclinical mastitis of ewes, respectively. These strains were shown to reproducibly induce severe (O11) or mild (O46) mastitis in experimental infections [15]. In the current study, they were comprehensively analyzed by a comparative genomic, transcriptomic and proteomic approach to identify staphylococcal factors that can be linked to mastitis severity in order to define strain characteristics associated with hypervirulence in mastitis.
Results
Genome analysis reveals minor differences between O11 and O46
In order to investigate the genetic bases for the high virulence of strain O11 in ewe mastitis, we determined and compared the genome sequences of strains O11 and O46 [23]. The great majority of the genes were found in both strains except for an additional serogroup B prophage (42 CDS) in O46 genome (Figure 1). O11 and O46 share high similarity with the recently sequenced ED133 genome [24] (Figure 1), a S. aureus strain isolated from ovine mastitis. Yet, ED133 belongs to the clonal complex CC133 (MLST) whereas O11 and O46 clustered in the same lineage as bovine strains found in CC130 [25]. In a study by Guinane et al, comparative genome analysis of ED133 in addition to other ruminant and human strains revealed molecular evidence for host-adaptation and several novel mobile genetic elements (MGE) encoding virulence proteins with attenuated or enhanced activity in ruminants [19]. In the current study, we found that most of the genes present in ED133 genome are present in O11 or O46 genomes (Figure 1). For example, both O11 and O46 carry the newly described phages related to the φSaov1 and φSaov3 phages from ED133 but do not contain φSaov2, reportedly unique to ED133, or SaPIov1, carrying an ovine allelic variant of sec (encoding staphylococcal enterotoxin type C). Nevertheless scn (staphylococcal complement inhibitor), vwb (von Willebrand factor-binding protein) and SAOV_2050 (hypothetical protein) carried by SaPIov2 pathogenicity island are identified in O11 and O46 sequences. In contrast to ED133, putative virulence factors edin-B and a homolog of etd carried by a putative pathogenicity island are present in both O11 and O46 [26].
Although O11 and O46 are clonally related as demonstrated by spa typing, PFGE analysis [27] and genome content, they contain Single Nucleotide Polymorphims (SNP) (around 1600 synonymous SNP and 1250 non synonymous SNP detected). SNP mediated diversification of genes encoding cell-wall associated proteins was previously observed [24], [28]. Here, comparison of O11 and O46 showed that the SNPs were evenly distributed around the genome and did not correlate with protein location or function.
O11 and O46 comparison also revealed 103 truncated genes (listed in supplemental data, Table S1) present in one strain or the other, corresponding to point mutations or indels causing a frameshift or leading to a premature stop codon. Among these 103 truncated genes, 37% are involved in cellular machinery, notably in gene regulation (8.7%), iron metabolism (3%), virulence (11%), and proteins of unknown function (36%). Truncated genes that may play a role in phenotype differences observed between O11 and O46 have been identified. For instance, 2 genes encoding enzymes involved in restriction/modification systems are found intact in O46 (046_2610 similar to type III restriction protein [29] and 046_0485 similar to HsdR type I restriction endonuclease [30] whereas they are truncated in O11 (Table S1). Transformation tests (electroporation with pMAD plasmid DNA directly extracted from E.coli DH5) on O11 and O46 revealed that only O11 is transformable with transformation efficiency comparable to that of S. aureus RN4220, bearing the same mutations [30]. Plasmidic DNA extracted from O11 transformants was successfully introduced into S. aureus MW2 and, to a lesser extend, into O46, suggesting that additional feature(s) impairs O46 transformability (see supplemental data, Table S2). Similarly, icaC is truncated in O11, and this correlates with a lower capacity for biofilm formation in O11 when compared to O46 (biofilm formation tested as described in [31]; see supplemental data, figure S1). Some of these differences have direct consequences on transcription as revealed by transcriptomic differences (18% of the truncated genes appeared underexpressed in O11 or O46 (Table S1)).
Comparison of O11 and O46 transcriptome during growth in mastitis-like conditions reveals major differences
Total RNA samples were prepared from O11 and O46 strains grown in deferoxamine-RPMI under anaerobic conditions to simulate the in vivo context [32]. Cells were harvested in exponential and stationary phase, and gene expression profiles determined. Fold changes in Table S3, S4, and S5 indicate the gene expression ratio between O11 and O46. Only ratios higher than 2 (overexpression in O11) and lower than 0.5 (overexpression in O46) were considered. Microarray analyses showed that 269 genes and 308 genes (Table S4 and S5) were differentially expressed between O11 and O46 during log and stationary phases respectively (Figure 2). The two strains had significantly different gene expression profiles suggesting that O11 and O46 respond to these growth conditions in distinct ways (Table S3, S4, S5).
Whatever the growth phase, O46 overexpressed genes encoding surface components, e.g. cap operon or adhesin genes (fnbB and clfA), in addition to other genes such as clpP and phage genes, whereas O11 overexpressed genes encoding secreted virulence factors (hla, hlgA, scpA, splE) and genes carried by pathogenicity islands as well as genes involved in iron metabolism (sir operon, sbnc, isdH). Overexpression of these latter genes in O11 may account for the higher sensitivity of O11 (compared to O46) to streptonigrin, an antibiotic which is toxic to cells in the presence of intracellular free iron (minimum inhibitory concentration was at least 4-fold higher for O46 than for O11).
O11 and O46 comparison revealed differences in two σ-factors: the sigS gene is indeed truncated in O46 (Table S1) and is found transcribed in O11, only, whatever the growth phases (confirmed by RT-qPCR, Table S3); the rsbU gene, part of sigB operon, is overexpressed in O11 during stationary phase (Table S3). Genome analysis of the two strains revealed that spoVG gene is truncated in O11 (Table S1). Both σB and σS appear to dramatically differ between O11 and O46. This may have huge consequences considering their central role in gene regulation and, subsequently, virulence expression.
Inasmuch as the accessory gene regulator (agr) system is central to the control of virulence gene expression, we specifically tested the agr functionality using RT-qPCR targeting hld (RNAIII) and agrA (RNAII). Both genes are expressed at similar levels in the two strains suggesting that agr does not contribute the differences observed between O11 and O46 gene expression profiles.
Differences in extracellular proteomes between O11 and O46: overproduction of exoproteins by O11
Protein samples representing total (whole-cell lysate), cell wall, and extracellular fractions were prepared from O11 and O46 strains grown in conditions identical to those of transcriptomic experiments [32]. At least 3 gels from 3 independent cultures for each strain and each compartment were compared. Image analysis identified 41 spots as being differentially expressed. The majority of differences were observed in extracellular samples, as illustrated in figure 3 (21 spots varied between O11 and O46 in supernatant gels whereas only 20 spots differed in both total and cell wall gels).
It is important to note that each spot may contain more than one unique protein as well as a given protein can be found in several spots. Hereafter, we present data resulting from protein identification (i.e. numbers refer to proteins and not to spots). Protein identification was carried out using Nano-LC analysis and results are listed in Table S6 for extracellular samples, table S7 and S8 (additional files) for total and cell wall samples respectively. Most proteins were common to O11 and O46 as indicated by protein patterns on the 2-D gels from total and cell wall extracts (figure S2 and S3, additional files). Some differences were however observed in both compartments but were mostly due to volume differences and few were due to the absence of the protein in one of the 2 strains. Some proteins were present in both strains but at clearly different positions on the 2-D gels, or they were found in several spots (see table S7), like the alkyl hydroperoxide reductase subunit C (spots T9, T10 on figure S2) or the phosphoglycerate kinase (spot T3 in O46 samples and T4 in O11 samples; figure S2). It should be noted that some spots corresponding to different Mr and/or pI contained the same protein (e.g. spots P7 and P8, or T5, T6 and T12, T13 containing the fructose 1,6-biphosphate aldolase; tables S5 and S7, and figures S1 and S2). In summary, 17 proteins were overproduced by O11 and 8 by O46 in total and cell wall fractions representing proteins from various functional categories including metabolism (14), cellular processes and signalling (4), information storage and processing (5) and unknown functions (2).
In contrast, the extracellular proteomes revealed more pronounced differences (figure 4A and 4B, and additional files table S6, S8, figure S4). A majority of proteins (28 out of the 35 proteins that differed between O11 and O46) were overproduced in O11 extracellular 2-D gels compared to O46. They are directly implicated in virulence (32%; e.g. LukE, LukM, Hla, or Hlg, or Sbi), or predicted to play a role in metabolism or other cellular processes (e.g. IsdA,B,C, and H, involved in iron metabolism). Surprisingly, when considering the predicted location of the proteins (according to the SurfG+ analysis of O11 and O46 genome sequences), many (43%) are predicted to be cytoplasmic (e.g. GAPDH, CspA, or PurH).
Some differences in protein expression can be explained by the presence of indels in one of the 2 strains, which most likely result in a difference in transcriptome and proteome. This is the case for IsdH, whose gene contains a deletion of 1215 bp in O46, and IsdA, whose gene contains an insertion of 45 bp in O46. For some proteins, transcriptomic results (overexpression of the corresponding genes) corroborated proteomic results as shown for Asp23, 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase, IsaA, DapA that are overexpressed by O46 or general stress protein 20 U, ClpL, Hla, mercury(II) reductase that are overexpressed by O11. Some proteins are overexpressed by one strain in log phase and by the other one during stationary phase. For instance, lukE and nuc are overexpressed in log phase at transcriptomic and proteomic levels (data not shown) by O46 but appeared to be overproduced by O11 during late stationary phase at proteomic level (S8 and S15 figure 4 and figure S4). Finally the overproduction of many proteins by O11 is not always explained by a difference in genome sequence or by higher gene expression. Post-transcriptional regulation, modifications or stability of proteins may contribute to these differences.
Some proteins differentially produced by O11 and O46 are distributed among a panel of strains isolated from clinical vs subclinical ewe mastitis
In order to identify protein candidates to characterize strains isolated from clinical versus subclinical mastitis, we screened an additional 4 strains isolated from subclinical (n = 2) and clinical (n = 2) cases of ewe mastitis for the presence of the previously identified proteins by proteome analysis of extracellular samples (2-D gels and Coomassie blue staining). Twenty two proteins that were identified as differentially produced by O11 and O46 were checked in other strains. At least 7 spots of these proteins appeared to be also overproduced either by clinical strains or by subclinical strains (figure 4C). SspB, AdhA, LdH, Gap, AhpC, SspA, CspA, Hla, LukM, LukF-PV were overproduced by O11, 1624 and 1628 (severe mastitis isolates) whereas O46_2740 gene product (with similarity to exfoliative toxin family) was overproduced by O46, O82 and O55 (subclinical mastitis isolates).
Discussion
S. aureus mastitis outcomes are highly variable and depend, in part, on strain-dependent features. Here we have achieved the first in-depth characterization of 2 S. aureus strains that were shown to reproducibly induce different symptoms in experimental mastitis despite close genotypic relatedness [15]. Complementary approaches were used to gain insight in the molecular basis of S. aureus virulence variability in mastitis. Taken together, the results show limited divergence in gene content and clear differences in gene expression. The combined results suggest that differences in iron metabolism, transcriptional regulators and exoprotein production capacity may contribute to the differences observed in mastitis severity induced by these two strains.
Ability to acquire DNA of exogenous origin and mobile genetic elements
Around 15% of the S. aureus genome is composed of MGE, i.e. bacteriophages, transposons, plasmids or pathogenicity islands that can be horizontally transferred from one isolate to another. The restriction-modification systems control in part, the uptake of foreign DNA by bacteria, by identifying and modifying specific DNA sequences so as to prevent the uptake of deleterious DNA for the bacteria (lysogenic bacteriophages or superfluous genes). Four restriction-modification systems have been described in S. aureus [30]. The enhanced ability of S. aureus strain RN4220 to accept foreign DNA is due to frameshift mutations in hsdR gene, a gene belonging to a type 1 restriction-modification system [30] and in a gene encoding a type III-like restriction endonuclease [29]. These two genes were found truncated in O11. This likely explains how O11 was amenable to transformation by plasmid DNA directly extracted from E. coli, whereas O46, which contains intact restriction modification genes was not. O11 is thus a naturally transformable strain, which can be useful to further study gene function in the pathogenesis of mastitis. S. aureus strains that are deficient in these restriction systems are hypersusceptible to the horizontal transfer of DNA [29]. In addition to being highly virulent, O11 strain may become a reservoir of horizontally acquired antibiotic resistance genes. Occurrence and spread of such strains in lifestock thus deserve special attention.
Surprisingly, O46, and not the transformable O11, contains an additional prophage. Furthermore, phage genes are expressed at higher levels in O46 compared to O11. Phages have been shown to play a crucial role in virulence [33]–[35]. The potential role of the additional prophage found in O46 in mastitis pathogenesis has to be further determined. In contrast, O11 overexpressed genes carried by pathogenicity islands although these latters are found in both O11 and O46 strains. Differences in the expression of MGE-related genes between strains O46 and O11 may contribute to the relative pathogenic potential of the 2 strains.
Dramatic differences between O11 and O46 gene expression profiles with regard to iron acquisition and metabolism
Iron is an absolute requirement for the growth of most microorganisms and serves as a cofactor in many enzymatic reactions and as a catalyst in electron transport processes [36]. It is however present at a very low concentration in many environments (e.g. in milk, the concentration of available iron is around 10−12 µM) [37]. Bacteria have developed various mechanisms to overcome iron restriction [38] and S. aureus is able to grow in the presence of extremely low (0.04 µM) iron concentrations [39]. Growth of strains O11 and O46 in deferoxamine-RPMI was carried out to mimic nutritional deficiencies relevant to the mammary gland. Differences regarding genes involved in iron acquisition were revealed through genome, transcriptome and proteome analyses. Indeed, O46 contains truncated genes related to different systems involved in iron metabolism (isdH, hrtB and feoA). Moreover, several genes involved in iron uptake (sir operon, some genes of isd operon, fer, sstA, sbnC) were overexpressed in O11. Such overexpression was confirmed at the proteomic level for some gene products, like IsdA, B, C, H, that were found overproduced by O11.
The S. aureus requirements for iron during infection can be satisfied through several different systems. Heme acquisition by the Isd system is required for full virulence in several models of pathogenesis [40]. It involves 9 proteins, 4 of which were found truncated (isdH) and or differentially expressed (isdA, isdB, isdC, and isdH) in strain O46. High intracellular concentrations of heme are toxic and S. aureus possesses de-toxification systems such as the HrtAB system, a hemin-regulated ABC transporter that protects S. aureus against hemin toxicity [41]. In O46, hrtB gene is truncated and it appears that the hemin uptake (isd system) and detoxification (hrtAB) pathways are attenuated in O46. In addition to its role in heme uptake, IsdH was shown to inhibit complement binding at the cell surface and so to contribute to the host immune evasion [42]. Interruption of isdH induced a reduced virulence in a mouse sepsis model [42] and a truncated isdH in O46 may take part in the reduced severity observed in ewe mastitis as well. Other iron uptake systems differ between O11 and O46. Iron can be acquired in its ferrous form via the widespread bacterial FeoAB system or via siderophore through the SstABCD, SirABC, FhuBCD systems. It is worth noting that feoA is truncated in O46 whereas several siderophore genes are overexpressed in O11. Notably sbnC, a gene encoding staphylobactin, an S. aureus siderophore and sirABC, the genes encoding its cell receptor are overexpressed in O11. It has been shown that siderophore production enhances the virulence of S. aureus [38]. S. aureus strains isolated from bovine mastitis have been shown to be able to overcome iron starvation [43]. However, the underlying mechanisms may vary between human and ruminant isolates. Genes involved in iron uptake or metabolism may reflect host tropism, as suggested by allelic variations reported in these genes in the recently released genome sequences of bovine and ovine isolates [24], [28]. O11 was more sensitive to streptonigrin when grown on deferoxamine-RPMI which suggests, together with higher expression of siderophore genes, that it has a better iron acquisition compared to O46. Strain-dependant expression of genes involved in iron acquisition or metabolism may impact on the severity of infection in vivo, in the mammary gland.
Overexpression of exoproteins by O11
Transcriptomic and proteomic comparison revealed that O11 overexpressed genes encoding exoproteins whereas O46 overexpressed genes encoding surface components. Notably, proteomic analysis of the culture supernatants revealed differences in toxin and protease expression. This was confirmed by the analysis of extracellular fraction in 4 additional strains. This global trend was also observed at the transcriptomic level but the difference in exoprotein levels did not always correlate with transcription implying differences in mRNA half-life or post-translational regulation. It is worth noting that some genes involved in the sec pathway (spsB and 4.5S RNA) and genes of the accessory sec system (secY2 and asp21) are overexpressed in O11 but a link between expression of these genes and the overproduction of exoproteins has still to be demonstrated.
Of note, differences were observed between the two strains with regard to transcriptional regulators. The sigS gene (σS plays a role in virulence in vivo [44]) is truncated in O46 whereas it is intact and transcribed in O11. The rsbU gene (part of sigB operon) is overexpressed in O11 compared to O46 (Table S3). Consequently in O11, one would expect an up-regulation of σB regulon including surface components like cap operon and surface proteins and a down-regulation of many toxins and secreted proteases [45]. Yet we observed the opposite situation in O11, and further found that the spoVG gene, part of yabJ-spoVG locus, a σB effector that modulates σB control over its dependent genes lacking an apparent σB promoter, is truncated in O11 (Table S1). This correlates well with the lower nuclease activity observed in O11, as expected according to [46] (Figure S5, supplemental data). Altogether, these differences might account for the differences in expression levels of genes encoding exoproteins (and putatively in mastitis severity) observed for the two strains [15]. Among the oversecreted proteins in O11, some candidates are indeed of special interest and make sense when considering the mastitis context. LukM/F' has been reported to be produced at higher levels during severe mastitis than in moderate mastitis [18], [19]. Production of α hemolysin has also been reported to play a role in mastitis severity [47] and to be involved in gangrenous mastitis [16], [17].
SspB and SspA belong to a proteolytic cascade where a metalloprotease aureolysin (Aur) activates a serine protease zymogen proSspA, which in turn activates the SspB cysteine protease [48]. SspA and SspB play an important role in virulence in a mouse abscess model [49] and they are both involved in the degradation of conjonctive tissue [50]. SspB plays a role in local inflammation of the tissue [51] and in blocking phagocytosis by neutrophils and inhibiting their chemotactic activity [52]. SspA and SspB have also been reported to be produced in vivo during gangrenous mastitis [15]. Other exoproteins (e.g. Gap, CspA, AhpC) were found overproduced in the extracellular fraction of O11 and 2 additional strains isolated from severe mastitis although they were predicted to be cytoplasmic. Gap has been reported to be surface located and able to bind to bovine transferrin, which is another high-affinity iron-scavenging mechanism [53]. CspA, a general stress protein is also a strong antigen in human sepsis caused by S. aureus [54]. AhpC is not required for virulence in vivo but plays a role in nasal colonization and has an important role in host-pathogen interaction [55]. Except Gap, these proteins have not previously been reported to be produced by mastitis S. aureus isolates. These three proteins have been reported to be present in S. aureus supernatant in other studies [56], [57] but are predicted to be localized in the cytoplasm. A new secretion system involved in protein export via vesicule secretion has recently been described [58]. The secretion mechanism of these proteins is still unknown but this may play a role in the oversecretion of some proteins by O11.
Only one protein was shown to be specifically associated to S. aureus strains isolated from moderate mastitis. This analog of exfoliative toxin D has also been shown to be produced in vivo [15]. Interestingly, a highly similar exfoliative toxin (76% homology) is also produced by coagulase negative staphylococci, which are the predominant pathogens responsible for subclinical mastitis. Whether this newly identified toxin is active and plays a role in mastitis remains to be determined.
These results clearly show that some exoproteins are specifically produced by isolates associated with severe mastitis. Proteins, like LukM/F' or α hemolysin, have been previously reported to be associated with severe mastitis. To our knowledge, this is the first time a link between proteins other than LukM/F' and Hla and mastitis severity is suggested. These proteins are thus good candidates for further investigation of their exact role in mastitis onset and severity.
Conclusion
The current study provides the first high resolution comparison of gene content and expression for S. aureus mastitis isolates from ovine origin. The results indicate several systems that may contribute to mastitis severity, including MGE, iron metabolism, sigma regulators and exoprotein production. These pathways represent excellent candidates for targeted studies of the molecular basis of S. aureus pathogenesis in ruminant mastitis.
Materials and Methods
Bacterial strains, growth conditions
Staphylococcus aureus O46 was isolated from a case of ovine subclinical mastitis and O11 from a lethal gangrenous mastitis [25]. S. aureus O46 and O11 are representative of the major lineage found associated to ewe mastitis in southeast of France [27], [59]. Four other S. aureus strains isolated from gangrenous and clinical ewe mastitis (1628 and 1624, respectively) and subclinical ewe mastitis (O55 and O82) were used in this study and were previously described [27]. Growth conditions and preparation of protein extracts were as described in Le Maréchal et al. 2009 [32]. Briefly, all cultures were performed as follows: Overnight cultures in BHI were diluted 1∶1000 in fresh RPMI 1640 medium (Sigma, Saint Quentin fallavier, France). Deferoxamine (0.15 mM; Sigma), an iron chelator, was added to RPMI (hereafter referred to as deferoxamine-RPMI). S. aureus strains were grown anaerobically in falcon tubes (50 ml) or in flasks (250 ml) filled up with medium and incubated at 37°C without agitation in anaerobic conditions. The same anaerobic conditions were used to compare O11 and O46 transcriptome and proteome. Minimum inhibitory concentration for streptonigrin (Sigma) was determined as follows. Overnight cultures of O11 and O46, on BHI, were 1/100 diluted and used to inoculate fresh deferoxamine-RPMI (2.5 mL, in 15-mL tubes) containing increasing concentrations of streptonigrin (0, 1.25, 2.5, 5, 10, and 20 ng/mL). Cultures were incubated at 37°C under agitation.
RNA, DNA and protein extraction
Protein samples for extracellular, cell wall or total fraction, RNA extraction and purification and genomic DNA extraction were exactly done as previously described [32], [59], [60].
Genome sequencing, assembly, annotation and comparison of O11 and O46
Whole genome sequencing and assembling strategy are described in [23]. Comparison and graphical mapping were performed using the MUMmer software package [61], the Circos visualization software [62] as well as an application developed in house. Coding sequences (CDSs) detection was performed with the Glimmer software application [63]. Annotations were imported from already annotated S. aureus strains and mapped to the corresponding CDSs by using an application developed in house as well as the Exonerate sequence alignment program [64]. These genome sequences have been deposited at DDBJ/EMBL/GenBank under the accession AEUQ00000000 (O11) and AEUR00000000 (O46) [23].
Microarray design and manufacturing
The microarray was manufactured by in situ synthesis of 60-base oligonucleotide probes (Agilent, Palo Alto, CA), selected as previously described [65]. The array covers 98% of all open reading frames (ORFs) annotated in strains N315, Mu50, COL, MRSA252, MSSA476, MW2, USA300_FPR3757, NCTC8325, RF122 including their respective plasmids.
Preparation of labeled nucleic acids for expression microarrays
Total RNA was purified from bacteria grown in deferoxamine-RPMI during log phase (OD600 = 0.5) and stationary phase (OD600 = 1). For each strain total RNA of three independent cultures was extracted as previously described [60]. After additional DNase treatment, noncontamination of the RNA sample by genomic DNA (gDNA) was confirmed by quantitative PCR on gyrB. Batches of 8 µg of total S. aureus RNA were labeled with Cy3-dCTP using SuperScript II (Invitrogen, Basel, Switzerland) following the manufacturer's instructions. Labeled products were then purified onto QiaQuick columns (Qiagen). The following steps were performed as described in [66].
Microarray analysis
Fluorescence intensities were extracted using Feature Extraction software (version 8; Agilent). Local background-subtracted signals were corrected for unequal dye incorporation or unequal load of the labelled product. Per chip normalizations were performed using the 50th percentile of all measurements for different hybridisations to make comparisons between different experiments valid. Data consisting of three independent biological experiments were analyzed using GeneSpring, version 8.0 (Silicon Genetics, Redwood City, CA) after per gene and per chip normalization. Statistical significance of differential gene expression was calculated by analysis of variance using GeneSpring, including the Benjamini and Hochberg false discovery rate correction of 5% (P value cutoff, 0.05) and higher than 2-fold induction or reduction of expression was accepted as differential expression.
Microarray data accession number
The microarray design and the complete dataset were deposited in the public repository database Gene Expresion Omnibus under the accession numbers GPL11137 and GSE25084, respectively.
qRT-PCR
To confirm microarray data, expression profiles of clfA, sigS, sirA, urea, hld, ahpF, phoP, agrA, capA were determined by quantitative reverse transcription-PCR (qRT-PCR) analyses. Primer sequences are given in Table S9. All primer efficiencies were tested for each strain and ranged between 85% and 110%. cDNA was synthesized using the high-capacity cDNA archive kit as recommended by the manufacturer (Applied Biosystems, Warrington, United Kingdom). Quantitative real-time PCR was performed using an Opticon 2 real-time PCR detector (Bio-Rad, Hercules, CA). The reaction mixture contained power Sybr green PCR master mix (1X; Applied Biosystems, Warrington, United Kingdom), each primer (0.5 µM), and 1 µg cDNA template. Thermal cycling consisted of 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. qRT-PCR analyses for all experimental time points were performed in triplicate (using three independent biological replicates). Calibration curves were generated to calculate the copy number for each gene in each sample. gyrA, ftsZ, hu and sodA [67] were tested to determine the best internal standards for normalization using the geNorm VBA applet for Microsoft Excel. gyrA, ftsZ and sodA were used as internal standards for exponential phase and ftsZ and sodA for stationary phase. The Ct values of genes of interest were transformed to quantities (number of copies) by using standard curves. Gene expression levels were calculated by dividing gene of interest quantities by the previously calculated normalization factor (according to the geNorm user manual). Statistical analyses were performed as in [68].
2-Dimensional Gel Electrophoresis
Protein samples (200 µg) were precipitated with 2D clean up kit (GE Healthcare, Orsay, France) according to the manufacturer's instructions. Pellets were solubilised in sample solution containing 7 M urea, 2 M thio-urea, 25 mM dithiothreitol (DTT), 4% (w/v) 3-[(3-Cholamidopropyl)dimethylammonio]-1-propane-sulfonate (CHAPS) and 2% (w/v) ampholyte containing buffer (IPG-Buffer 4–7 or 3–10 NL, GE Healthcare). Isoelectric focusing was carried out using pH 4 to 7 (Cell wall and total proteins) or 3 to 10 NL (extracellular fraction) 13 cm Immobiline Dry Strips on a Multiphor II electrophoresis system (Amersham Biosciences) as described previously [15]. The second dimension separation was performed on an Ettan dalt electrophoresis system (GE Healthcare) using 14% acrylamide separating gels without a stacking gel at a voltage of 50 V for 1 h and 180 V for 7 h. Low molecular weight markers (GE Healthcare) were used as the standards. Gels were stained with R250 Coomassie blue (Serva, Heildelberg, Germany). Three extractions from three different cultures were carried out to perform 2-D gels. Stained 2-D gels were scanned with Image Scanner II (Amersham biosciences) and image analysis was performed with ImageMaster 2D platinum software as previously described [69], [70].
Nano-LC analysis
Proteins were identified by tandem mass spectrometry (MS/MS) after an in-gel trypsin digestion adapted from Shevchenko [71] and described in details in [15]. Briefly, gel pieces were excised from the gel. In-gel trypsin digestion was performed overnight at 37°C. After concentration, the supernatants containing peptides were analyzed using an on-line liquid chromatography tandem mass spectrometry (MS/MS) setup. A full continuous MS scan was carried out followed by three data-dependent MS/MS scans. Spectra were collected in the selected mass range 400 to 2,000 m/z for MS and 60 to 2,000 m/z for MS/MS spectra. The three most intense ions from the MS scan were selected individually for collision-induced dissociation (1+ to 4+ charged ions were considered for the MS/MS analysis). The mass spectrometer was operated in data-dependent mode automatically switching between MS and MS/MS acquisition. The proteins present in the samples were identified from MS and MS/MS data by using MASCOT v.2.2 software for search into two concatenated databases: (i) a homemade database containing all the predicted proteins of the O11 and O46 strains used in this study as deduced from their genome [23] and (ii) a portion of the UniProtKB database corresponding to the Staphylococcus aureus taxonomic group (http://www.uniprot.org/).
Supporting Information
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: The authors have no support or funding to report.
References
- 1.Le Marechal C, Thiery R, Vautor E, Le Loir Y. Mastitis impact on technological properties of milk and quality of milk products-a review. Dairy Science & Technology. 2011;91:247–282. [Google Scholar]
- 2.Halasa T, Nielen M, Huirne RBM, Hogeveen H. Stochastic bio-economic model of bovine intramammary infection. Livest Sci. 2009;124:295–305. [Google Scholar]
- 3.Badiou C, Dumitrescu O, Croze M, Gillet Y, Dohin B, et al. Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses. Clin Microbiol Infect. 2008;14:1180–1183. doi: 10.1111/j.1469-0691.2008.02105.x. [DOI] [PubMed] [Google Scholar]
- 4.Cremieux AC, Dumitrescu O, Lina G, Vallee C, Cote JF, et al. Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS ONE. 2009;4:e7204. doi: 10.1371/journal.pone.0007204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dorrell N, Hinchliffe SJ, Wren BW. Comparative phylogenomics of pathogenic bacteria by microarray analysis. Curr Opin Microbiol. 2005;8:620–626. doi: 10.1016/j.mib.2005.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Foster TJ. The Staphylococcus aureus “superbug”. J Clin Invest. 2004;114:1693–1696. doi: 10.1172/JCI23825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nimmo GR, Coombs GW, Pearson JC, O'Brien FG, Christiansen KJ, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust. 2006;184:384–388. doi: 10.5694/j.1326-5377.2006.tb00287.x. [DOI] [PubMed] [Google Scholar]
- 8.Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978–984. doi: 10.3201/eid0908.030089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70:631–641. doi: 10.1128/IAI.70.2.631-641.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.O'Callaghan RJ, Callegan MC, Moreau JM, Green LC, Foster TJ, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571–1578. doi: 10.1128/iai.65.5.1571-1578.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jett M, Brinkley W, Neill R, Gemski P, Hunt R. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect Immun. 1990;58:3494–3499. doi: 10.1128/iai.58.11.3494-3499.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Grumann D, Scharf SS, Holtfreter S, Kohler C, Steil L, et al. Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J Immunol. 2008;181:5054–5061. doi: 10.4049/jimmunol.181.7.5054. [DOI] [PubMed] [Google Scholar]
- 13.Zollner TM, Wichelhaus TA, Hartung A, Von MC, Wagner TO, et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy. 2000;30:994–1000. doi: 10.1046/j.1365-2222.2000.00848.x. [DOI] [PubMed] [Google Scholar]
- 14.Burvenich C, Van MV, Mehrzad J, ez-Fraile A, Duchateau L. Severity of E. coli mastitis is mainly determined by cow factors. Vet Res. 2003;34:521–564. doi: 10.1051/vetres:2003023. [DOI] [PubMed] [Google Scholar]
- 15.Le Marechal C, Jardin J, Jan G, Even S, Pulido C, et al. Staphylococcus aureus seroproteomes discriminate ruminant isolates causing mild or severe mastitis. Vet Res. 2011;42:35. doi: 10.1186/1297-9716-42-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Adlam C, Ward PD, McCartney AC, Arbuthnott JP, Thorley CM. Effect immunization with highly purified alpha- and beta-toxins on staphylococcal mastitis in rabbits. Infect Immun. 1977;17:250–256. doi: 10.1128/iai.17.2.250-256.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ward PD, Adlam C, McCartney AC, Arbuthnott JP, Thorley CM. A histopathological study of the effects of highly purified staphlococcal alpha and beta toxins on the lactating mammary gland and skin of the rabbit. J Comp Pathol. 1979;89:169–177. doi: 10.1016/0021-9975(79)90056-2. [DOI] [PubMed] [Google Scholar]
- 18.Rainard P. Staphylococcus aureus leucotoxin LukM/F' is secreted and stimulates neutralising antibody response in the course of intramammary infection. Vet Res. 2007;38:685–696. doi: 10.1051/vetres:2007026. [DOI] [PubMed] [Google Scholar]
- 19.Guinane CM, Sturdevant DE, Herron-Olson L, Otto M, Smyth DS, et al. Pathogenomic analysis of the common bovine Staphylococcus aureus clone (ET3): emergence of a virulent subtype with potential risk to public health. J Infect Dis. 2008;197:205–213. doi: 10.1086/524689. [DOI] [PubMed] [Google Scholar]
- 20.Jones TO, Wieneke AA. Staphylococcal toxic shock syndrome. Vet Rec. 1986;119:435–436. doi: 10.1136/vr.119.17.435. [DOI] [PubMed] [Google Scholar]
- 21.Matsunaga T, Kamata S, Kakiichi N, Uchida K. Characteristics of Staphylococcus aureus isolated from peracute, acute and chronic bovine mastitis. J Vet Med Sci. 1993;55:297–300. doi: 10.1292/jvms.55.297. [DOI] [PubMed] [Google Scholar]
- 22.Haveri M, Roslof A, Rantala L, Pyorala S. Virulence genes of bovine Staphylococcus aureus from persistent and nonpersistent intramammary infections with different clinical characteristics. J Appl Microbiol. 2007;103:993–1000. doi: 10.1111/j.1365-2672.2007.03356.x. [DOI] [PubMed] [Google Scholar]
- 23.Le Marechal C, Hernandez D, Schrenzel J, Even S, Berkova N, et al. Genome Sequence of two Staphylococcus aureus ovine strains that induce severe (strain O11) and mild (strain O46) mastitis. J Bacteriol. 2011;193:2353–2354. doi: 10.1128/JB.00045-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Guinane CM, Ben Zakour NL, Tormo-Mas MA, Weinert LA, Lowder BV, et al. Evolutionary genomics of Staphylococcus aureus reveals insights into the origin and molecular basis of ruminant host adaptation. Genome Biol Evol. 2010;2:454–466. doi: 10.1093/gbe/evq031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Vautor E, Cockfield J, Le Marechal C, Le Loir Y, Chevalier M, et al. Difference in virulence between Staphylococcus aureus isolates causing gangrenous mastitis versus subclinical mastitis in a dairy sheep flock. Vet Res. 2009;40:56–67. doi: 10.1051/vetres/2009039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, et al. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun. 2002;70:5835–5845. doi: 10.1128/IAI.70.10.5835-5845.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vautor E, Abadie G, Guibert JM, Huard C, Pepin M. Genotyping of Staphylococcus aureus isolated from various sites on farms with dairy sheep using pulsed-field gel electrophoresis. Vet Microbiol. 2003;96:69–79. doi: 10.1016/s0378-1135(03)00207-4. [DOI] [PubMed] [Google Scholar]
- 28.Herron-Olson L, Fitzgerald JR, Musser JM, Kapur V. Molecular correlates of host specialization in Staphylococcus aureus. PLoS ONE. 2007;2:e1120. doi: 10.1371/journal.pone.0001120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Corvaglia AR, Francois P, Hernandez D, Perron K, Linder P, et al. A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains. Proc Natl Acad Sci U S A. 2010;107:11954–11958. doi: 10.1073/pnas.1000489107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Waldron DE, Lindsay JA. Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol. 2006;188:5578–5585. doi: 10.1128/JB.00418-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Stenz L, Francois P, Fischer A, Huyghe A, Tangomo M, et al. Impact of oleic acid (cis-9-octadecenoic acid) on bacterial viability and biofilm production in Staphylococcus aureus. FEMS Microbiol Lett. 2008;287:149–155. doi: 10.1111/j.1574-6968.2008.01316.x. [DOI] [PubMed] [Google Scholar]
- 32.Le Maréchal C, Jan G, Even S, McCulloch JA, Azevedo V, et al. Development of serological proteome analysis of mastitis by Staphylococcus aureus in ewes. J Microbiol Methods. 2009;79:131–136. doi: 10.1016/j.mimet.2009.08.017. [DOI] [PubMed] [Google Scholar]
- 33.Bae T, Baba T, Hiramatsu K, Schneewind O. Prophages of Staphylococcus aureus Newman and their contribution to virulence. Mol Microbiol. 2006;62:1035–1047. doi: 10.1111/j.1365-2958.2006.05441.x. [DOI] [PubMed] [Google Scholar]
- 34.Novick RP. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid. 2003;49:93–105. doi: 10.1016/s0147-619x(02)00157-9. [DOI] [PubMed] [Google Scholar]
- 35.van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol. 2006;188:1310–1315. doi: 10.1128/JB.188.4.1310-1315.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Somerville GA, Proctor RA. At the Crossroads of Bacterial Metabolism and Virulence Factor Synthesis in Staphylococci. Microbiology and Molecular Biology Reviews. 2009;73:233–248. doi: 10.1128/MMBR.00005-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ster C, Beaudoin F, Diarra MS, Jacques M, Malouin F, et al. Evaluation of some Staphylococcus aureus iron-regulated proteins as vaccine targets. Vet Immunol Immunopathol. 2010;136:311–318. doi: 10.1016/j.vetimm.2010.03.010. [DOI] [PubMed] [Google Scholar]
- 38.Dale SE, Doherty-Kirby A, Lajoie G, Heinrichs DE. Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun. 2004;72:29–37. doi: 10.1128/IAI.72.1.29-37.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Trivier D, Courcol RJ. Iron depletion and virulence in Staphylococcus aureus. FEMS Microbiol Lett. 1996;141:117–127. doi: 10.1111/j.1574-6968.1996.tb08373.x. [DOI] [PubMed] [Google Scholar]
- 40.Grigg JC, Ukpabi G, Gaudin CF, Murphy ME. Structural biology of heme binding in the Staphylococcus aureus Isd system. J Inorg Biochem. 2010;104:341–348. doi: 10.1016/j.jinorgbio.2009.09.012. [DOI] [PubMed] [Google Scholar]
- 41.Attia AS, Benson MA, Stauff DL, Torres VJ, Skaar EP. Membrane Damage Elicits an Immunomodulatory Program in Staphylococcus aureus. Plos Pathogens. 2010;6 doi: 10.1371/journal.ppat.1000802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Visai L, Yanagisawa N, Josefsson E, Tarkowski A, Pezzali I, et al. Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology. 2009;155:667–679. doi: 10.1099/mic.0.025684-0. [DOI] [PubMed] [Google Scholar]
- 43.Diarra MS, Petitclerc D, Lacasse P. Response of Staphylococcus aureus isolates from bovine mastitis to exogenous iron sources. J Dairy Sci. 2002;85:2141–2148. doi: 10.3168/jds.S0022-0302(02)74292-6. [DOI] [PubMed] [Google Scholar]
- 44.Shaw LN, Lindholm C, Prajsnar TK, Miller HK, Brown MC, et al. Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS ONE. 2008;3:e3844. doi: 10.1371/journal.pone.0003844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Bischoff M, Dunman P, Kormanec J, Macapagal D, Murphy E, et al. Microarray-based analysis of the Staphylococcus aureus sigma(B) regulon. Journal of Bacteriology. 2004;186:4085–4099. doi: 10.1128/JB.186.13.4085-4099.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Schulthess B, Meier S, Homerova D, Goerke C, Wolz C, et al. Functional characterization of the sigmaB-dependent yabJ-spoVG operon in Staphylococcus aureus: role in methicillin and glycopeptide resistance. Antimicrob Agents Chemother. 2009;53:1832–1839. doi: 10.1128/AAC.01255-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Jonsson P, Lindberg M, Haraldsson I, Wadstrom T. Virulence of Staphylococcus-Aureus in A Mouse Mastitis Model - Studies of Alpha-Hemolysin, Coagulase, and Protein-A As Possible Virulence Determinants with Protoplast Fusion and Gene Cloning. Infection and Immunity. 1985;49:765–769. doi: 10.1128/iai.49.3.765-769.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Nickerson NN, Prasad L, Jacob L, Delbaere LT, McGavin MJ. Activation of the SspA serine protease zymogen of Staphylococcus aureus proceeds through unique variations of a trypsinogen-like mechanism and is dependent on both autocatalytic and metalloprotease-specific processing. J Biol Chem. 2007;282:34129–34138. doi: 10.1074/jbc.M705672200. [DOI] [PubMed] [Google Scholar]
- 49.Shaw L, Golonka E, Potempa J, Foster SJ. The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology. 2004;150:217–228. doi: 10.1099/mic.0.26634-0. [DOI] [PubMed] [Google Scholar]
- 50.Oscarsson J, Tegmark-Wisell K, Arvidson S. Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII). Int J Med Microbiol. 2006;296:365–380. doi: 10.1016/j.ijmm.2006.02.019. [DOI] [PubMed] [Google Scholar]
- 51.Kulig P, Zabel BA, Dubin G, Alllen SJ, Ohyama T, et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol. 2007;178:3713–3720. doi: 10.4049/jimmunol.178.6.3713. [DOI] [PubMed] [Google Scholar]
- 52.Smagur J, Guzik K, Magiera L, Bzowska M, Gruca M, et al. A New Pathway of Staphylococcal Pathogenesis: Apoptosis-Like Death Induced by Staphopain B in Human Neutrophils and Monocytes. J Innate Immun. 2009;1:98–108. doi: 10.1159/000181014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Goji N, Potter AA, Perez-Casal J. Characterization of two proteins of Staphylococcus aureus isolated from bovine clinical mastitis with homology to glyceraldehyde-3-phosphate dehydrogenase. Vet Microbiol. 2004;99:269–279. doi: 10.1016/j.vetmic.2003.12.009. [DOI] [PubMed] [Google Scholar]
- 54.Lorenz U, Ohlsen K, Karch H, Hecker M, Thiede A, et al. Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. FEMS Immunol Med Microbiol. 2000;29:145–153. doi: 10.1111/j.1574-695X.2000.tb01517.x. [DOI] [PubMed] [Google Scholar]
- 55.Cosgrove K, Coutts G, Jonsson IM, Tarkowski A, Kokai-Kun JF, et al. Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol. 2007;189:1025–1035. doi: 10.1128/JB.01524-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ziebandt AK, Kusch H, Degner M, Jaglitz S, Sibbald MJ, et al. Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation. Proteomics. 2010;10:1634–1644. doi: 10.1002/pmic.200900313. [DOI] [PubMed] [Google Scholar]
- 57.Burlak C, Hammer CH, Robinson MA, Whitney AR, McGavin MJ, et al. Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol. 2007;9:1172–1190. doi: 10.1111/j.1462-5822.2006.00858.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Lee EY, Choi DY, Kim DK, Kim JW, Park JO, et al. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics. 2009;9:5425–5436. doi: 10.1002/pmic.200900338. [DOI] [PubMed] [Google Scholar]
- 59.Vautor E, Magnone V, Rios G, Le BK, Bergonier D, et al. Genetic differences among Staphylococcus aureus isolates from dairy ruminant species: a single-dye DNA microarray approach. Vet Microbiol. 2009;133:105–114. doi: 10.1016/j.vetmic.2008.06.006. [DOI] [PubMed] [Google Scholar]
- 60.Even S, Charlier C, Nouaille S, Ben Zakour NL, Cretenet M, et al. Staphylococcus aureus virulence expression is impaired by Lactococcus lactis in mixed cultures. Appl Environ Microbiol. 2009;75:4459–4472. doi: 10.1128/AEM.02388-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, et al. Versatile and open software for comparing large genomes. Genome Biol. 2004;5:R12. doi: 10.1186/gb-2004-5-2-r12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19:1639–1645. doi: 10.1101/gr.092759.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Delcher AL, Harmon D, Kasif S, White O, Salzberg SL. Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 1999;27:4636–4641. doi: 10.1093/nar/27.23.4636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Slater GS, Birney E. Automated generation of heuristics for biological sequence comparison. BMC Bioinformatics. 2005;6:31. doi: 10.1186/1471-2105-6-31. 1471-2105-6-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Charbonnier Y, Gettler B, Francois P, Bento M, Renzoni A, et al. A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus. BMC Genomics. 2005;6:95. doi: 10.1186/1471-2164-6-95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Pohl K, Francois P, Stenz L, Schlink F, Geiger T, et al. CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J Bacteriol. 2009;191:2953–2963. doi: 10.1128/JB.01492-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Duquenne M, Fleurot I, Aigle M, Darrigo C, Borezee-Durant E, et al. Tool for quantification of staphylococcal enterotoxin gene expression in cheese. Appl Environ Microbiol. 2010;76:1367–1374. doi: 10.1128/AEM.01736-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Even S, Leroy S, Charlier C, Zakour NB, Chacornac JP, et al. Low occurrence of safety hazards in coagulase negative staphylococci isolated from fermented foodstuffs. Int J Food Microbiol. 2010;139:87–95. doi: 10.1016/j.ijfoodmicro.2010.02.019. [DOI] [PubMed] [Google Scholar]
- 69.Dumas E, Meunier B, Berdague JL, Chambon C, Desvaux M, et al. Comparative analysis of extracellular and intracellular proteomes of Listeria monocytogenes strains reveals a correlation between protein expression and serovar. Appl Environ Microbiol. 2008;74:7399–7409. doi: 10.1128/AEM.00594-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Park SA, Lee HW, Hong MH, Choi YW, Choe YH, et al. Comparative proteomic analysis of Helicobacter pylori strains associated with iron deficiency anemia. Proteomics. 2006;6:1319–1328. doi: 10.1002/pmic.200500293. [DOI] [PubMed] [Google Scholar]
- 71.Shevchenko A, Sunyaev S, Liska A, Bork P, Shevchenko A. Nanoelectrospray tandem mass spectrometry and sequence similarity searching for identification of proteins from organisms with unknown genomes. Methods Mol Biol. 2003;211:221–234. doi: 10.1385/1-59259-342-9:221. [DOI] [PubMed] [Google Scholar]
- 72.Le Loir Y, Gruss A, Ehrlich SD, Langella P. Direct screening of recombinants in gram-positive bacteria using the secreted staphylococcal nuclease as a reporter. J Bacteriol. 1994;176:5135–5139. doi: 10.1128/jb.176.16.5135-5139.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.